Eastman Chemical (NYSE:EMN) Issues Earnings Results

Eastman Chemical (NYSE:EMN) released its earnings results on Thursday. The basic materials company reported $0.75 earnings per share for the quarter, missing the consensus estimate of $0.76 by ($0.01), Zacks reports. Eastman Chemical had a net margin of 7.75% and a return on equity of 12.89%. The business had revenue of $1.97 billion for the quarter, compared to the consensus estimate of $2.03 billion.

Eastman Chemical Price Performance

NYSE EMN opened at $69.04 on Friday. Eastman Chemical has a 1 year low of $56.11 and a 1 year high of $103.82. The stock’s 50-day moving average price is $64.80 and its two-hundred day moving average price is $65.23. The company has a current ratio of 1.76, a quick ratio of 0.86 and a debt-to-equity ratio of 0.82. The company has a market cap of $7.88 billion, a PE ratio of 11.53, a PEG ratio of 6.78 and a beta of 1.23.

Eastman Chemical Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, January 8th. Shareholders of record on Monday, December 15th were issued a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a yield of 4.9%. The ex-dividend date was Monday, December 15th. This is a boost from Eastman Chemical’s previous quarterly dividend of $0.83. Eastman Chemical’s dividend payout ratio is presently 56.09%.

Analyst Ratings Changes

A number of research firms recently weighed in on EMN. Citigroup increased their price objective on shares of Eastman Chemical from $72.00 to $75.00 and gave the stock a “buy” rating in a report on Thursday, January 15th. UBS Group decreased their price objective on Eastman Chemical from $75.00 to $73.00 and set a “buy” rating for the company in a report on Wednesday, November 5th. Wells Fargo & Company reaffirmed an “equal weight” rating and set a $70.00 target price on shares of Eastman Chemical in a research note on Friday, December 19th. KeyCorp decreased their price target on Eastman Chemical from $76.00 to $74.00 and set an “overweight” rating for the company in a research note on Friday, January 9th. Finally, Bank of America cut their price objective on shares of Eastman Chemical from $78.00 to $74.00 and set a “buy” rating on the stock in a research note on Tuesday, October 14th. Six investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat, Eastman Chemical has an average rating of “Hold” and a consensus price target of $78.54.

Eastman Chemical News Summary

Here are the key news stories impacting Eastman Chemical this week:

• Positive Sentiment: Underlying profitability and valuation may cushion downside — Eastman still shows mid-teens ROE and positive margins, and a relatively low P/E vs. its history, which could limit further multiple compression.
• Neutral Sentiment: Company released its quarter press release and slide deck for investors to review the detail behind results and guidance; useful for modeling revisions. Eastman Announces Fourth-Quarter and Full-Year 2025 Financial Results
• Neutral Sentiment: Analyst consensus remains cautious — the street consensus rating is a “Hold,” suggesting limited near-term analyst upgrade pressure. Eastman Chemical Company (NYSE:EMN) Receives Consensus Rating of “Hold” from Analysts
• Neutral Sentiment: Pre-earnings coverage highlighted key metrics investors wanted to see, providing context for why misses mattered to the market. Wall Street’s Insights Into Key Metrics Ahead of Eastman Chemical (EMN) Q4 Earnings
• Negative Sentiment: Q4 EPS missed estimates — Eastman reported $0.75 EPS, below consensus (~$0.76–$0.79), marking a sharp decline from last year and prompting margin/volume concerns. Eastman Chemical (EMN) Q4 Earnings and Revenues Miss Estimates
• Negative Sentiment: Revenue and volumes were weaker than expected — management cited lower volumes, which directly hit top-line and is the primary reason the stock sold off. Eastman Chemical shares fall after revenue miss on lower volumes
• Negative Sentiment: Q1 guidance disappointed — the outlook for the first quarter fell short of expectations, amplifying the negative reaction as investors trim exposure ahead of revised forecasts. Eastman Chemical falls as Q1 guidance disappoints

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of EMN. MUFG Securities EMEA plc acquired a new position in shares of Eastman Chemical in the 2nd quarter valued at about $25,000. Danske Bank A S purchased a new stake in Eastman Chemical in the 3rd quarter worth approximately $50,000. Employees Retirement System of Texas acquired a new stake in shares of Eastman Chemical during the 3rd quarter valued at $55,000. EverSource Wealth Advisors LLC grew its holdings in shares of Eastman Chemical by 181.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 958 shares of the basic materials company’s stock valued at $72,000 after acquiring an additional 618 shares in the last quarter. Finally, Parallel Advisors LLC grew its holdings in shares of Eastman Chemical by 22.0% during the 3rd quarter. Parallel Advisors LLC now owns 1,434 shares of the basic materials company’s stock valued at $90,000 after acquiring an additional 259 shares in the last quarter. Hedge funds and other institutional investors own 83.65% of the company’s stock.

About Eastman Chemical

Eastman Chemical Company (NYSE: EMN) is a global specialty materials company that develops, manufactures and markets a broad range of advanced materials, chemicals and fibers. Its product portfolio spans performance additives, functional products, and engineered plastics designed to enhance the durability, appearance and performance of end products across diverse industries.

The company’s main business activities include the production of specialty chemicals used in adhesives, coatings, building materials and consumer care applications, as well as high-performance plastics for packaging, automotive and electronics markets.